Skip to main content

Table 1 Demographics and co-morbidities of patient groups

From: Splenectomy for hypersplenism with or without preoperative splenic artery embolisation

 

Study group (n = 50)

Control group (n = 50)

p value

Age (years, mean ± SD (range))

38 ± 8.1 (28–62)

34 ± 7.8 (25–60)

0.893

Gender (n (%))

Male

23 (46)

20 (40)

0.686

Female

27 (54)

30 (60)

Splenic size (cm, mean ± SD (range))

16.2 ± 3.9 (13–26)

16.4 ± 4.8 (13–25)

0.685

Child-Pugh class (n (%))

A

47 (94)

48 (96)

 

B

3 (6)

2 (4)

 

C

0

0

 

Co-morbidities (n (%))

DM

7 (14)

6 (12)

0.659

Cholestasis

17 (34)

15 (30)

0.365

Hypertension

3 (6)

4 (8)

0.786

CBC (mean ± SD (range))

 Platelet (U/μL)

8500 ± 2444 (6500–18,600)

9200 ± 2765 (6500–17,400)

0.646

 WBCs (U/μL)

2700 ± 549 (1150–3200)

2580 ± 642 (1190–3140)

0.413

 HB (gm/dL)

8.3 ± 0.79 (7.5–10.8)

8.5 ± 0.82 (7.8–10.4)

0.250

Liver function tests (mean ± SD (range))

 ALT (U/μL)

72.8 ± 3.5 (67.2–79.5)

73.4 ± 3.7 (65.8–78.6)

0.359

 AST (U/μL)

70.6 ± 2.1 (66.8–79.2)

71.2 ± 2.9 (67.4–77.9)

0.329

 TB (μmol/L)

23.4 ± 3.3 (18.5–29.4)

22.8 ± 3.2 (18.9–28.6)

0.257

  1. OS open splenectomy, SAE splenic artery embolisation, DM diabetes mellitus, CBC complete blood count, WBC white blood cell, HB haemoglobin, ALT alanine aminotransferase, AST aspartate aminotransferase, TB total bilirubin